News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Murphy Sean
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/14/2023 |
4
| Murphy Sean (CFO) has filed a Form 4 on TriSalus Life Sciences, Inc.
Txns:
| Granted 62,500 options to buy
@ $12, valued at
$750k
|
|
08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/25/2022 |
4
| Murphy Sean (Director) has filed a Form 4 on Radius Health, Inc.
Txns:
| Granted 5,500 shares
@ $0 Granted 10,000 options to buy
@ $6.4, valued at
$64k
|
|
02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/25/2021 |
4
| Murphy Sean (Director) has filed a Form 4 on Radius Health, Inc.
Txns:
| Granted 20,000 options to buy
@ $22, valued at
$440k
|
|
08/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/15/2020 |
4
| Murphy Sean (10% Owner) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns:
| Converted 7,013,918 shares
@ $0 Converted 1,168,985 shares
@ $0 Converted 690,124 shares
@ $0 Converted 315,098 shares
@ $0 Bought 10,000 shares
@ $16, valued at
$160k
Converted 8,746,356 preferred shares
@ $0 Converted 1,457,725 preferred shares
@ $0 Converted 860,585 preferred shares
@ $0 Converted 392,927 preferred shares
@ $0 |
|
07/13/2020 |
4
| Murphy Sean (10% Owner) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns:
| Granted 20,000 options to buy
@ $16, valued at
$320k
|
|
06/07/2018 |
4
| Murphy Sean (Director) has filed a Form 4 on Novan, Inc.
Txns:
| Granted 20,000 options to buy
@ $3.08, valued at
$61.6k
|
|
06/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
09/22/2016 |
4
| Murphy Sean (Director) has filed a Form 4 on Novan, Inc.
Txns:
| Granted 14,484 options
@ $11, valued at
$159.3k
|
|
|
|